Deposition of complement C3 and factor H in tissue traumatized by burn injury

Immunopharmacology

Volumn 42, Issue 1-3, 1999, Pages 195-202

  Sriramarao, P ^a   Discipio, Richard G ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Burn; C3; Factor H; Trauma

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CELL RECEPTOR; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; HUMAN SERUM ALBUMIN; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL; BURN; CAPILLARY; COMPLEMENT DEPOSITION; CONFERENCE PAPER; CONTROLLED STUDY; FLUORESCENCE; INFLAMMATION; INTERSTITIUM; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VENULE;

ANIMALS; BURNS; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT FACTOR H; MICE; MICE, NUDE;

EID: 0033041211     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00024-7     Document Type: Conference Paper

References (38)

1. Avery V.M., Gordon D.L. Characterization of factor H binding to human polymorphonuclear leukocytes. J. Immunol. 151:1993;5545-5553.
2. Bengtsson A., Bengtson J.-P., Rydenhag A., Roxvall L., Heideman M. Accumulation of anaphylatoxins and terminal complement complexes in inflammatory fluids. J. Intern. Med. 228:1990;173-176.
3. Blackmore T.K., Hellwage J., Sadlon T.A., Higgs N., Zipfel P.F., Ward H.M., Gordon D.L. Identification of the second heparin binding domain in human complement factor H. J. Immunol. 160:1998;3342-3348.
4. Blackmore T.K., Sadlon T.A., Ward H.M., Lublin D.M., Gordon D.L. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J. Immunol. 157:1996;5422-5427.
5. Borgstrom P., Hughes G.K., Hansell P., Wolitzky B.A., Sriramarao P. Leukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin and β2 integrins in lymphotoxin-mediated leukocyte recruitment in tumor microvessels. J. Clin. Invest. 99:1997;2246-2253.
6. Delibrias, C., Fischer, E., Kazachtkine, M.D. 1998. Receptors for human C3 fragments. In: Rother, K., Till, G.O., Hansch, G.M. (Eds.), The Complement System, Springer-Verlag, Berlin, pp. 211-220.
7. DiScipio R.G. The binding of human complement proteins C5, factor B, β1H, and properdin to complement fragment C3b on zymosan. Biochem. J. 199:1981;485-496.
8. DiScipio R.G., Daffern P.J., Schraufstatter I.U., Sriramarao P. Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves αMβ2 (CD11B/CD18). J. Immunol. 160:1998;4057-4066.
9. DiScipio R.G., Pinz Sweeney S. The fractionation of human plasma proteins: II. The purification of human complement proteins C3, C3u, and C5 by application of affinity chromatography. Prot. Exp. Purif. 5:1994;170-177.
10. Erdei A., Sim R.B. Complement factor H-binding protein of Raji cells and tonsil B lymphocytes. Biochem. J. 246:1987;149-156.
11. Estaller C., Koistinen V., Schwaeble W., Dierich M.P., Weiss E.H. Cloning of the 1.4-kb mRNA species of human complement factor H reveals a novel member of the short consensus repeat classical 150-kDa molecule. J. Immunol. 146:1991;3190-3196.
12. Estaller C., Schwaeble W., Dierich M., Weiss E.H. Human complement factor H: two factor H proteins are derived from alternatively spliced transcripts. Eur. J. Immunol. 21:1991;799-802.
13. Fishelson Z. Complement C3: a molecular mosaic of binding sites. Mol. Immunol. 28:1991;545-552.
14. Fontaine M., Demares M.J., Koistinen V., Day A.J., Davrinche C., Sim R.B., Ripoche J. Truncated forms of human complement factor H. Biochem. J. 258:1989;927-930.
15. Gallinaro R., Cheadle W.G., Applegate K., Polk H.C. The role of the complement system in trauma and infection. Surg. Gynecol. Obstet. 174:1992;435-440.
16. Gardner W.D., White P.J., Hoch S.O. Identification of a major human serum DNA-binding protein as β1H of the alternative pathway of complement activation. Biochem. Biophys. Res. Commun. 94:1980;61-67.
17. Gelfand J.A., Donelan M., Burke J.F. Preferential activation and depletion of the alternative complement pathway by burn injury. Ann. Surg. 198:1983;58-62.
18. Gordon D.L., Kaufman R.M., Blackmore T.K., Kwong J., Lublin D.M. Identification of complement regulatory domains in human factor H. J. Immunol. 155:1995;348-356.
19. Hartung H.P., Hadding U., Bitter-Suermann D., Gemsa D. Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H. Clin. Exper. Immunol. 56:1984;453-458.
20. Hellwage J., Kuhn S., Zipfel P.F. The human complement regulatory factor H like protein 1, which represents a truncated form of factor H, displays cell attachment activity. Biochem. J. 326:1997;321-327.
21. Hindmarsh E.J., Marks R.M. Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells. J. Immunol. 160:1998;6128-6136.
22. Hugli T.E. Structure and function of C3a anaphylatoxin. Current Topics in Microbiology and Immunology. 153:1990;181-208.
23. Kazatchkine M.D., Fearon D.T., Austen K.F. Human alternative pathway: membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b. J. Immunol. 122:1979;75-81.
24. Lambris J.D., Dobson N.J., Ross G.D. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for β1H globulin. J. Exp. Med. 152:1980;1625-1644.
25. Law S.K., Lichtenberg N.A., Levine R.P. Covalent binding and hemolytic activity of complement proteins. Proc. Natl. Acad. Sci. U.S.A. 77:1980;7194-7198.
26. Lehr H., Leunig M., Menger M.D., Messmer K. Dorsal skinfold chamber technique for intravital microscopy on striated muscle in nude mice. Am. J. Path. 143:1993;1055-1062.
27. Ljunghusen O., Lundahl J., Netteblad H., Nilsson B., Sjogren F., Stendahl O. Endotoxemia and complement activation after severe burn injuries-effects on leukocytes, soluble selectins, and inflammatory cytokines. Inflammation. 20:1996;229-241.
28. Nabil K., Rihn B., Jaurand M.C., Vignaud J.M., Ripoche J., Martinet Y., Martinet N. Identification of human complement factor H as a chemotactic protein for monocytes. Biochem. J. 326:1997;338-377.
29. Ohtsuka H., Imamura T., Matsushita M., Tanase S., Ogawa M., Kambara T. Thrombin generates monocyte chemotactic activity from complement factor H. Immunology. 80:1993;140-145.
30. Sharma J.K., Pangburn M.K. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 93:1996;10996-11001.
31. Sim R.B., Twose T.M., Paterson D.S., Sim E. The covalent binding reaction of complement component C3. Biochem. J. 193:1981;115-127.
32. Tack B.F., Harrison R.A., Janatova J., Thomas M.L. Evidence for presence of an internal thiol ester bond in the third component of human complement. Proc. Natl. Acad. Sci. U.S.A. 77:1980;5764-5768.
33. Timpl R. Proteoglycans of basement membranes. Experientia. 49:1993;417-428.
34. Weiler J.M., Daha M.R., Austen K.F., Fearon D.T. Control of the amplification convertase of complement by the plasma protein β1H. Proc. Natl. Acad. Sci. U.S.A. 73:1976;3268-3272.
35. Whaley K., Ruddy S. Modulation of the alternative complement pathway by β1H globulin. J. Exp. Med. 144:1976;1147-1163.
36. Wright S.D., Rao P.E., Van Voorhis W.C., Craigmyle L.S., Iida K., Talle M.A., Westberg E.F., Goldstein G., Silverstein S.C. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 80:1983;5699-5703.
37. Wright S.D., Silverstein S.C. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J. Exp. Med. 158:1983;2016-2023.
38. Zipfel P.F., Skerka C. Complement factor H and related proteins: an expanding family of complement-regulatory proteins? Immunol. Today. 15:1994;121-126.